Received Mar 31, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
lot of muscle pain throughout my body; Arthritis was much worse; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of arthritis aggravated in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Concurrent medical conditions included arthritis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced arthritis aggravated (Verbatim: Arthritis was much worse) and muscle pain (Verbatim: lot of muscle pain throughout my body). The action taken with Arexvy was unknown. The outcome of the arthritis aggravated was resolved (duration 3 days) and the outcome of the muscle pain was not reported. It was unknown if the reporter considered the arthritis aggravated and muscle pain to be related to Arexvy. It was unknown if the company considered the arthritis aggravated and muscle pain to be related to Arexvy. Additional Information: GSK receipt date: 21-MAR-2026 The patient really felt that he/she was coming down with something. The patient had lot of muscle pain throughout body. The patient's arthritis was much worse than others days and this lasted for about 3 days. The batch number was not provided, and we are unable to contact the reporter.
Arthritis